Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results

BACKGROUND: Although triplet regimen of docetaxel, cisplatin, and 5-FU (DCF) reportedly yields high response rates for metastatic squamous cell carcinoma of the esophagus (SCCE), it has severe toxicity. In our previous phase II trial, grade 3/4 toxicities of neutropenia occurred in 68.8% of the pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojima, Toshiyasu, Nakamura, Masaki, Nakamori, Mikihito, Katsuda, Masahiro, Hayata, Keiji, Kitadani, Junya, Maruoka, Shimpei, Shimokawa, Toshio, Yamaue, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368232/
https://www.ncbi.nlm.nih.gov/pubmed/30783514
http://dx.doi.org/10.18632/oncotarget.26614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368232/
https://www.ncbi.nlm.nih.gov/pubmed/30783514
http://dx.doi.org/10.18632/oncotarget.26614

Ejemplares similares